Adam Berman
Chief Executive Officer
About Us
Developing therapies for heart failure.
At Alleviant Medical, we're committed to transforming the future of heart failure care.
Our Mission
To improve the lives of millions of patients suffering from heart failure.
Our team
A collective of multi-disciplinary professionals with extensive experience in the industry, a demonstrated track record and a shared commitment to addressing one of healthcare's greatest unmet needs.
Mary Byron
Chief Financial Officer
Jacob Kriegel, MD
Co-founder & Chief Medical Officer
Michael McCully
Senior VP, Market & Clinical Development
Sara Vidmar
Senior VP, Clinical, Regulatory & Quality
Tom Pate
VP, Research & Development
Lisa Diehl
VP, Therapy Development, North America
Stacia Kraus
VP, Clinical Affairs
Dana Mester
VP, Technical Operations
Mark Perkins
VP, Clinical Marketing
Tomasz Berdzik
Senior Director, Therapy Development, EMEA
Eric Fox
VP, Manufacturing
Avni Patel
Co-founder & Manager, Clinical Marketing
Marlene Ivezaj
Manager, Therapy Development, North America
Kathy Nix
Manager, Therapy Development, North America
Tayla Cannon
Manager, Therapy Development, North America
Nadia Coughlan
Manager, Therapy Development, North America
Dennis Joseph
Manager, Therapy Development, North America
Patty Lightcap
Senior Clinical Specialist & Global Training Manager
Spring McDaniel
Clinical Specialist, North America
Nicole Baker
Clinical Specialist, North America
Bailey Estes
Clinical Liaison, North America
Andreas Kuhl
Director, Therapy Development, EMEA
Marieke Vijge
Director, Clinical, EMEA
Maurizio Allegri
Manager, Therapy Development, EMEA
Adrian Klapyta
Manager, Clinical Development, EMEA
Howard Ellis
Clinical Specialist, EMEA
Rita Cabaco
Clinical Specialist, EMEA
Jen Olson
Director, Clinical, North America & ANZ
Nancy Ackley
Senior Manager, Clinical Trials
Erika Sullivan
Manager, Clinical Trials
Zach Meagher
Clinical Trial Associate
Kiersten Soderman
Director, Regulatory & Quality
Jessica Szarkowski
Manager, Quality
Jessica Herman
Manager, Regulatory
Kelsey Farley
Senior Manager, Data Management
Amy Lyons
Senior Clinical Data Specialist
Jeanne Bjergo
Manager, Clinical Safety
Hennessey McIlvaine
Clinical Safety Specialist
Lily Mitchell
Program Director, ALLAY-HF
Drew Gant
Director, Product Development
Michael Hemati
Senior Product Engineer
Kevin Lessard
Senior Product Engineer
Suhie Kim
Manufacturing Technician
Drew Isaak
Senior Process Development Engineer
Zach Berman
Project Engineer
Teresa Metzger
Clinical Operations Associate
Alexa Wichmann
Associate Controller, Finance
Jen Guardipee
Office Manager
Newsroom
View all14 January 2025
Alleviant Medical Secures $90 Million Financing to Expand Interventional Heart Failure Pivotal Trial Program
7 January 2025
Novel Heart Failure Technology from Alleviant Medical Gains FDA Approval for New Pivotal Trial and Breakthrough Designation for Significant Patient Population
26 January 2023
Alleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical Trial
20 May 2022
No-implant interatrial shunt device to treat heart failure patients reveals promising multi-center clinical data
17 May 2021
Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences
Patents
This website is provided to satisfy the virtual patent marking provisions of various jurisdictions including the virtual patent marking provisions of the America Invents Act and provide notice under 35 U.S.C. §287 (a). The following list of products and patents may not be all inclusive.
Alleviant’s Products and Services may be covered by one or more of the following U.S. Patents:
U.S. Patent No. 11,304,753
U.S. Patent No. 11,612,432
U.S. Patent No. 11,871,987
Alleviant’s Products and Services may be covered by one or more of the following U.S. Patents:
U.S. Patent No. 11,304,753
U.S. Patent No. 11,612,432
U.S. Patent No. 11,871,987